DNA Repair and Prostate Cancer: A Field Ripe for Harvest

Alan H Bryce1, Oliver Sartor2, Johann de Bono3

  • 1Department of Oncology, Mayo Clinic, Scottsdale, AZ, USA.

European Urology
|July 9, 2020
PubMed

Insights

Poly (ADP-ribose) polymerase (PARP) inhibitors show antitumor activity in prostate cancer. Two PARP inhibitors are FDA-approved for metastatic castrate-resistant prostate cancer, with more in clinical trials.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Metastatic castrate-resistant prostate cancer (mCRPC) remains a significant clinical challenge.
  • DNA repair defects are increasingly recognized as actionable targets in mCRPC.

Discussion:

  • Poly (ADP-ribose) polymerase (PARP) inhibitors have demonstrated promising antitumor activity in mCRPC.
  • The efficacy of PARP inhibitors is linked to specific DNA repair gene alterations.

Key Insights:

  • Olaparib and rucaparib are US Food and Drug Administration (FDA)-approved for mCRPC with select DNA repair defects.
  • Ongoing clinical trials are evaluating talazoparib, veliparib, and niraparib in prostate cancer.

Outlook:

  • Further advancements in PARP inhibitor therapy are anticipated for prostate cancer treatment.
  • Personalized medicine approaches targeting DNA repair pathways will likely expand.

Related Concept Videos

Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
4.8K
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
40.3K
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
33.1K
Overview of DNA Repair02:25

Overview of DNA Repair

9.4K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.7K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.8K